Asia Pacific Cancer Therapies Market
Segments - by Treatment Types (Chemotherapy, Target Therapy, Immunotherapy, Hormone Therapy, and Other Treatment Types), Cancer Types (Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Respiratory/Lung Cancer, and Other Cancer Types), End-users (Hospitals, Specialty Clinics, and Radiation Therapy Centre) and Countries (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The Asia Pacific cancer therapies market size is estimated to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising cases of people having cancer.
Cancer is a disease characterized by uncontrolled cell proliferation. It is one of the world's worst diseases and the second leading cause of death. Cancer is a type of abnormal cell development that can spread to other parts of the body. Humans have been impacted by approximately 100 different forms of cancer. According to the American Cancer Society, 4.2 new instances of aggressive cancer were identified in China in 2015. There has been a considerable increase in the number of individuals suffering from various forms of cancer over the previous decade. One of the most significant risk factors for cancer is smoking. The most frequent cancers in China include lung, stomach, colorectum, liver, and esophagus. Population expansion, age, environmental pollution, and bad eating habits are all contributing to an increase in cancer burden and, as a result, cancer treatments.
Targeted therapy is a type of cancer treatment that differs from standard chemotherapy. The medicines used in target treatment operate by focusing on certain genes or proteins found in cancer cells. With the discovery of tumor cell-specific genes, recent advances in biological treatments have broadened the scope of therapeutic targets for cancer treatment. Among many cancer treatments, immunotherapies/biologics are developing as a promising therapy for finding a lasting cure for various cancer types.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing support from the government in terms of initiatives and awareness programs regarding the hazardous effects of smoking is anticipated to spur market expansion in the coming years.
- Expanding patient support programmes is estimated to drive market growth during the forecast period.
- Treatment side effects and high therapy costs may impede market expansion over the predicted time.
Scope of the Report
The report on the Asia Pacific cancer therapies market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Asia Pacific Cancer Therapies Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Treatment Types (Chemotherapy, Target Therapy, Immunotherapy, Hormone Therapy, and Other Treatment Types), Cancer Types (Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Respiratory/Lung Cancer, and Other Cancer Types), and End-users (Hospitals, Specialty Clinics, and Radiation Therapy Centre) |
|
Countries Scope |
China, Japan, India, Australia, South Korea, and Rest of Asia Pacific |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Amgen, Astra Zeneca, Bayer AG, Johnson & Johnson, and Merck & Co. Inc. |
Market Segment Insights
Target therapy segment is projected to account for a key market share
In terms of treatment types, the Asia Pacific cancer therapies market is bifurcated into chemotherapy, target therapy, immunotherapy, hormone therapy, and other treatment types. The target therapy segment is expected to account for a key share of the market during the forecast period owing to its selectivity for cancer cells while avoiding harm to non-target cells. A rise in R&D and the growing occurrence of various forms of cancer throughout the world are two additional significant reasons driving the segment's growth.
Respiratory/Lung cancer segment is expected to register at a rapid pace
On the basis of cancer types, the Asia Pacific cancer therapies market is segregated into blood cancer, breast cancer, prostate cancer, gastrointestinal cancer, gynecologic cancer, respiratory/lung cancer, and other cancer types. The respiratory/lung cancer segment is expected to account for a key share of the market in the coming years due to a surge in the cases of lung cancer in recent times.
Specialty clinics segment is anticipated to register at a rapid CAGR
In terms of end-users, the Asia Pacific cancer therapies market is divided into hospitals, specialty clinics, and radiation therapy centre. The hospitals segment is expected to account for a key share of the market during the forecast period owing to the rising prevalence of cancer cases and availability of hospitals in every place.
China is anticipated to dominate the market
On the basis of countries, the Asia Pacific cancer therapies market is classified as China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. The market of China is anticipated to expand at an impressive CAGR during the forecast period. The countries’ market growth can be attributed to changing lifestyles.
Segments
Segments Covered in the Report
The Asia Pacific cancer therapies market has been segmented on the basis of
Treatment Types
- Chemotherapy
- Target Therapy
- Immunotherapy
- Hormone Therapy
- Other Treatment Types
Cancer Types
- Blood Cancer
- Breast Cancer
- Prostate Cancer
- Gastrointestinal Cancer
- Gynecologic Cancer
- Respiratory/Lung Cancer
- Other Cancer Types
End-users
- Hospitals
- Specialty Clinics
- Radiation Therapy Centre
Countries
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Key Players
- Amgen
- Astra Zeneca
- Bayer AG
- Johnson & Johnson
- Merck & Co. Inc.
Competitive Landscape
Key players competing in the Asia Pacific cancer therapies market include Amgen, Astra Zeneca, Bayer AG, Johnson & Johnson, and Merck & Co. Inc. Some of these players are investing in several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cancer Therapies Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cancer Therapies Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cancer Therapies Market - Supply Chain
4.5. Global Cancer Therapies Market Forecast
4.5.1. Cancer Therapies Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cancer Therapies Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Cancer Therapies Market Absolute $ Opportunity
5. Global Cancer Therapies Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Cancer Therapies Market Size and Volume Forecast by Types
5.3.1. Chemotherapy
5.3.2. Target Therapy
5.3.3. Immunotherapy
5.3.4. Hormone Therapy
5.3.5. Other Treatment Types
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Cancer Therapies Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Cancer Therapies Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Cancer Therapies Demand Share Forecast, 2019-2026
7. North America Cancer Therapies Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Cancer Therapies Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Cancer Therapies Market Size and Volume Forecast by Types
7.4.1. Chemotherapy
7.4.2. Target Therapy
7.4.3. Immunotherapy
7.4.4. Hormone Therapy
7.4.5. Other Treatment Types
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Cancer Therapies Demand Share Forecast, 2019-2026
8. Latin America Cancer Therapies Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Cancer Therapies Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Cancer Therapies Market Size and Volume Forecast by Types
8.4.1. Chemotherapy
8.4.2. Target Therapy
8.4.3. Immunotherapy
8.4.4. Hormone Therapy
8.4.5. Other Treatment Types
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Cancer Therapies Demand Share Forecast, 2019-2026
9. Europe Cancer Therapies Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Cancer Therapies Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Cancer Therapies Market Size and Volume Forecast by Types
9.4.1. Chemotherapy
9.4.2. Target Therapy
9.4.3. Immunotherapy
9.4.4. Hormone Therapy
9.4.5. Other Treatment Types
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Cancer Therapies Demand Share Forecast, 2019-2026
10. Asia Pacific Cancer Therapies Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Cancer Therapies Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Cancer Therapies Market Size and Volume Forecast by Types
10.4.1. Chemotherapy
10.4.2. Target Therapy
10.4.3. Immunotherapy
10.4.4. Hormone Therapy
10.4.5. Other Treatment Types
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Cancer Therapies Demand Share Forecast, 2019-2026
11. Middle East & Africa Cancer Therapies Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Cancer Therapies Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Cancer Therapies Market Size and Volume Forecast by Types
11.4.1. Chemotherapy
11.4.2. Target Therapy
11.4.3. Immunotherapy
11.4.4. Hormone Therapy
11.4.5. Other Treatment Types
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Cancer Therapies Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Cancer Therapies Market: Market Share Analysis
12.2. Cancer Therapies Distributors and Customers
12.3. Cancer Therapies Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Amgen
12.4.2. Astra Zeneca
12.4.3. Bayer AG
12.4.4. Johnson & Johnson
12.4.5. Merck & Co. Inc.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cancer Therapies Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cancer Therapies Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cancer Therapies Market - Supply Chain
4.5. Global Cancer Therapies Market Forecast
4.5.1. Cancer Therapies Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cancer Therapies Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Cancer Therapies Market Absolute $ Opportunity
5. Global Cancer Therapies Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Cancer Therapies Market Size and Volume Forecast by Types
5.3.1. Chemotherapy
5.3.2. Target Therapy
5.3.3. Immunotherapy
5.3.4. Hormone Therapy
5.3.5. Other Treatment Types
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Cancer Therapies Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Cancer Therapies Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Cancer Therapies Demand Share Forecast, 2019-2026
7. North America Cancer Therapies Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Cancer Therapies Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Cancer Therapies Market Size and Volume Forecast by Types
7.4.1. Chemotherapy
7.4.2. Target Therapy
7.4.3. Immunotherapy
7.4.4. Hormone Therapy
7.4.5. Other Treatment Types
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Cancer Therapies Demand Share Forecast, 2019-2026
8. Latin America Cancer Therapies Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Cancer Therapies Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Cancer Therapies Market Size and Volume Forecast by Types
8.4.1. Chemotherapy
8.4.2. Target Therapy
8.4.3. Immunotherapy
8.4.4. Hormone Therapy
8.4.5. Other Treatment Types
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Cancer Therapies Demand Share Forecast, 2019-2026
9. Europe Cancer Therapies Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Cancer Therapies Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Cancer Therapies Market Size and Volume Forecast by Types
9.4.1. Chemotherapy
9.4.2. Target Therapy
9.4.3. Immunotherapy
9.4.4. Hormone Therapy
9.4.5. Other Treatment Types
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Cancer Therapies Demand Share Forecast, 2019-2026
10. Asia Pacific Cancer Therapies Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Cancer Therapies Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Cancer Therapies Market Size and Volume Forecast by Types
10.4.1. Chemotherapy
10.4.2. Target Therapy
10.4.3. Immunotherapy
10.4.4. Hormone Therapy
10.4.5. Other Treatment Types
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Cancer Therapies Demand Share Forecast, 2019-2026
11. Middle East & Africa Cancer Therapies Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Cancer Therapies Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Cancer Therapies Market Size and Volume Forecast by Types
11.4.1. Chemotherapy
11.4.2. Target Therapy
11.4.3. Immunotherapy
11.4.4. Hormone Therapy
11.4.5. Other Treatment Types
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Cancer Therapies Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Cancer Therapies Market: Market Share Analysis
12.2. Cancer Therapies Distributors and Customers
12.3. Cancer Therapies Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Amgen
12.4.2. Astra Zeneca
12.4.3. Bayer AG
12.4.4. Johnson & Johnson
12.4.5. Merck & Co. Inc.
Our Clients
Related Reports
Some other reports from this category!
